Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

NCT04900259 is registered in ClinicalTrials.gov with Ankara Training and Research Hospital as lead sponsor.

NCT NCT04900259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04900259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations
Lead sponsor
Ankara Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2021
Completion date
August 15, 2021
Enrollment
183 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, covid19